Beneficient (NASDAQ:BENF – Get Free Report) was the target of a large growth in short interest in February. As of February 15th, there was short interest totalling 207,800 shares, a growth of 34.0% from the January 31st total of 155,100 shares. Based on an average daily trading volume, of 619,500 shares, the short-interest ratio is presently 0.3 days. Currently, 5.7% of the shares of the company are sold short.
Beneficient Trading Down 5.8 %
Beneficient stock opened at $0.38 on Tuesday. Beneficient has a 1-year low of $0.38 and a 1-year high of $13.22. The firm has a 50 day simple moving average of $0.61 and a 200 day simple moving average of $1.05.
Institutional Inflows and Outflows
Several large investors have recently bought and sold shares of the company. Jane Street Group LLC bought a new position in Beneficient in the 4th quarter valued at $39,000. Stifel Financial Corp boosted its holdings in Beneficient by 198.4% in the 4th quarter. Stifel Financial Corp now owns 72,500 shares of the company’s stock valued at $54,000 after purchasing an additional 48,200 shares during the period. Ausdal Financial Partners Inc. boosted its holdings in Beneficient by 214.3% in the 4th quarter. Ausdal Financial Partners Inc. now owns 63,379 shares of the company’s stock valued at $47,000 after purchasing an additional 43,217 shares during the period. Virtu Financial LLC bought a new position in Beneficient in the 4th quarter valued at $28,000. Finally, State Street Corp bought a new position in Beneficient in the 3rd quarter valued at $73,000. 90.57% of the stock is owned by institutional investors.
Beneficient Company Profile
Beneficient, a technology-enabled financial services company, provides liquidity solutions and related trustee, custody and trust administrative services to participants in the alternative asset industry in the United States. It operates through Ben Liquidity, Ben Custody, and Customer ExAlt Trusts segments.
Further Reading
- Five stocks we like better than Beneficient
- 3 Warren Buffett Stocks to Buy Now
- Rocket Lab’s Plunge: Buy the Dip or Watch from the Sidelines?
- The Risks of Owning Bonds
- Mediterranean Growth Monster: CAVA Keeps Surging—Buy the Dip?
- 5 Top Rated Dividend Stocks to Consider
- Is the S&P 500 Ready to Rally? A $1.8M Bet on SPY Says Yes
Receive News & Ratings for Beneficient Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Beneficient and related companies with MarketBeat.com's FREE daily email newsletter.